Register Now: IKRIS Breast Cancer Awareness Run 2022

Tag Archives: HER2 +Ve breast cancer

FDA Has Granted Enhertu Breakthrough Therapy Designation (BTD) for Adult Patients with Unresectable/Metastatic HER2 +Ve Breast Cancer

The Food and Drug Administration has granted Enhertu (trastuzumab deruxtecan) Breakthrough Therapy Designation (BTD) in the US to treat adult […]

ikrisuser
October 7, 2021